RESUMO
Parvovirus B19 (B19V) infects human erythroid progenitor cells (EPCs) and causes several hematological disorders and fetal hydrops. Amino acid (aa) 5-68 of minor capsid protein VP1 (VP1u5-68aa) is the minimal receptor binding domain for B19V to enter EPCs. Here, we carried out a genome-wide CRISPR-Cas9 guide RNA screen and identified tyrosine protein kinase receptor UFO (AXL) as a proteinaceous receptor for B19V infection of EPCs. AXL gene silencing in ex vivo expanded EPCs remarkably decreased B19V internalization and replication. Additions of the recombinant AXL extracellular domain or a polyclonal antibody against it upon infection efficiently inhibited B19V infection of ex vivo expanded EPCs. Moreover, B19V VP1u interacted with the recombinant AXL extracellular domain in vitro at a relatively high affinity (KD = 103 nM). Collectively, we provide evidence that AXL is a co-receptor for B19V infection of EPCs.
Assuntos
Receptor Tirosina Quinase Axl , Eritema Infeccioso , Parvovirus B19 Humano , Humanos , Proteínas do Capsídeo/genética , Proteínas do Capsídeo/metabolismo , Eritema Infeccioso/metabolismo , Parvovirus B19 Humano/genética , Parvovirus B19 Humano/metabolismo , Ligação Proteica , Receptor Tirosina Quinase Axl/metabolismoRESUMO
Human parvovirus B19 (B19V) infection has symptoms similar to those of antiphospholipid syndrome (APS). Antibodies against B19VVP1 unique region (VP1u) exhibit activity similar to that of antiphospholipid antibodies (aPLs) by inducing vascular endothelial cell adhesion factors and APSlike syndrome. Previous studies have identified an effect of aPLs on angiogenesis. However, little is understood regarding the effect of antiB19VVP1u antibodies on angiogenesis. The present study investigated the effects of antiB19VVP1u antibodies on the expression of adhesion molecules and angiogenic signaling using an aPLinduced human umbilical vein endothelial cell (HUVEC) model, and trypan blue staining and western blotting. The effect of B19VVP1u antibodies on vascular endothelial growth factor (VEGF) expression in A549 cells, another wellknown model used to study angiogenesis, was also examined. Significantly higher intracellular adhesion molecule 1 expression was observed following treatments with 10% fetal calf serum (FCS), aPL immunoglobulin G (IgG), B19VVP1u IgG or B19VNS1 IgG, compared with in the normal human (NH) IgGtreated cells. Conversely, significantly higher vascular cellular adhesion molecule 1 was only detected in HUVECs treated with B19VVP1u IgG. Significantly increased integrin ß1 was detected in HUVECs treated with aPL IgG or B19VVP1u IgG, whereas no difference in integrin ß1 was observed in those treated with 10% FCS, NH IgG or B19VNS1 IgG. No difference in AKTmTORS6 ribosomal protein (S6RP) signaling was observed in HUVECs treated with B19VP1u IgG or B19VNS1 IgG, compared with NH IgGtreated cells. Significantly higher human inducible factor1α was detected in HUVECs treated with 10% FCS, aPL IgG, B19VVP1u IgG or B19VNS1 IgG, compared with in NH IgGtreated cells. However, there was no difference in the level of VEGF observed among HUVECs treated with NH IgG, B19VVP1u IgG or B19VNS1 IgG. Notably, no difference in VEGF level was observed in A549 cells treated with NH IgG, aPL IgG, B19VVP1u IgG or B19VNS1 IgG. These findings suggest that antiB19VVP1u antibodies may serve a role in activating adhesion molecules, but not in AKTmTORS6RP signaling.
Assuntos
Anticorpos Antivirais/farmacologia , Síndrome Antifosfolipídica , Eritema Infeccioso , Imunoglobulina G/farmacologia , Neovascularização Fisiológica/efeitos dos fármacos , Parvovirus B19 Humano/metabolismo , Transdução de Sinais/efeitos dos fármacos , Células A549 , Anticorpos Antifosfolipídeos/farmacologia , Síndrome Antifosfolipídica/metabolismo , Síndrome Antifosfolipídica/patologia , Síndrome Antifosfolipídica/virologia , Eritema Infeccioso/metabolismo , Eritema Infeccioso/patologia , Células Endoteliais da Veia Umbilical Humana , HumanosRESUMO
Globoside (Gb4) is considered the primary receptor of parvovirus B19 (B19V); however, its expression does not correlate well with the attachment and restricted tropism of the virus. The N terminus of VP1 (VP1u) of B19V interacts with an as-yet-unknown receptor required for virus internalization. In contrast to Gb4, the VP1u cognate receptor is expressed exclusively in cells that B19V can internalize. With the aim of clarifying the role of Gb4 as a B19V receptor, we knocked out the gene B3GalNT1 coding for the enzyme globoside synthase in UT7/Epo cells. Consequently, B3GalNT1 transcripts and Gb4 became undetectable in the knockout (KO) cells without affecting cell viability and proliferation. Unexpectedly, virus attachment, internalization, and nuclear targeting were not disturbed in the KO cells. However, NS1 transcription failed, and consequently, genome replication and capsid protein expression were abrogated. The block could be circumvented by transfection with a B19V infectious clone, indicating that Gb4 is not required after the generation of viral double-stranded DNA with resolved inverted terminal repeats. While in wild-type (WT) cells, occupation of the VP1u cognate receptor with recombinant VP1u disturbed virus binding and blocked the infection, antibodies against Gb4 had no significant effect. In a mixed population of WT and KO cells, B19V selectively infected WT cells. This study demonstrates that Gb4 does not have the expected receptor function, as it is dispensable for virus entry; however, it is essential for productive infection, explaining the resistance of the rare individuals lacking Gb4 to B19V infection.IMPORTANCE Globoside has long been considered the primary receptor of B19V. However, its expression does not correlate well with B19V binding and uptake and cannot explain the pathogenesis or the remarkable narrow tissue tropism of the virus. By using a knockout cell line, we demonstrate that globoside does not have the expected function as a cell surface receptor required for B19V entry, but it has an essential role at a postentry step for productive infection. This finding explains the natural resistance to infection associated with individuals lacking globoside, contributes to a better understanding of B19V restricted tropism, and offers novel strategies for the development of antiviral therapies.
Assuntos
Eritema Infeccioso/metabolismo , Eritema Infeccioso/virologia , Globosídeos/metabolismo , Interações Hospedeiro-Patógeno , Parvovirus B19 Humano/fisiologia , Internalização do Vírus , Replicação Viral , Proteínas do Capsídeo/genética , Proteínas do Capsídeo/metabolismo , Linhagem Celular , Células Cultivadas , Técnicas de Silenciamento de Genes , Humanos , Ligação Proteica , Receptores Virais/metabolismo , Proteínas não Estruturais Virais/metabolismoRESUMO
Viral infection-associated kidney diseases are an emerging public health issue in both developing and developed countries. Many new viruses have emerged with new paradigms of kidney injury, either directly through their cytopathic effect or indirectly through immune-mediated glomerulopathy, tubulointerstitial disease, and acute kidney injury as part of multiorgan failure. Herein, we will discuss Parvovirus, which causes glomerulopathy, and Hanta, Ebola, and Dengue viruses, which cause viral hemorrhagic fever and acute kidney injury. Clinical manifestations also depend on extrarenal organ systems involved. Diagnosis of these viral infections is mainly based on a high index of suspicion, serologic testing, and isolation of viral DNA/RNA. Management is largely conservative, as specific antiviral agents are unavailable.
Assuntos
Injúria Renal Aguda/metabolismo , Dengue/metabolismo , Eritema Infeccioso/metabolismo , Glomerulonefrite/metabolismo , Infecções por Hantavirus/metabolismo , Doença pelo Vírus Ebola/metabolismo , Síndrome Nefrótica/metabolismo , Injúria Renal Aguda/diagnóstico , Injúria Renal Aguda/fisiopatologia , Injúria Renal Aguda/terapia , DNA Viral/análise , Dengue/diagnóstico , Dengue/fisiopatologia , Dengue/terapia , Eritema Infeccioso/diagnóstico , Eritema Infeccioso/fisiopatologia , Eritema Infeccioso/terapia , Glomerulonefrite/diagnóstico , Glomerulonefrite/fisiopatologia , Glomerulonefrite/terapia , Infecções por Hantavirus/diagnóstico , Infecções por Hantavirus/fisiopatologia , Infecções por Hantavirus/terapia , Doença pelo Vírus Ebola/diagnóstico , Doença pelo Vírus Ebola/fisiopatologia , Doença pelo Vírus Ebola/terapia , Humanos , Nefrite/diagnóstico , Nefrite/metabolismo , Nefrite/fisiopatologia , Nefrite/terapia , Síndrome Nefrótica/diagnóstico , Síndrome Nefrótica/fisiopatologia , Síndrome Nefrótica/terapia , Infecções por Parvoviridae/diagnóstico , Infecções por Parvoviridae/metabolismo , Infecções por Parvoviridae/fisiopatologia , Infecções por Parvoviridae/terapia , RNA Viral/análise , Testes SorológicosRESUMO
Human parvovirus B19 (B19V) expresses a single precursor mRNA (pre-mRNA), which undergoes alternative splicing and alternative polyadenylation to generate 12 viral mRNA transcripts that encode two structural proteins (VP1 and VP2) and three nonstructural proteins (NS1, 7.5-kDa protein, and 11-kDa protein). Splicing at the second 5' donor site (D2 site) of the B19V pre-mRNA is essential for the expression of VP2 and the 11-kDa protein. We previously identified that cis-acting intronic splicing enhancer 2 (ISE2) that lies immediately after the D2 site facilitates the recognition of the D2 donor for its efficient splicing. In this study, we report that ISE2 is critical for the expression of the 11-kDa viral nonstructural protein. We found that ISE2 harbors a consensus RNA binding motif protein 38 (RBM38) binding sequence, 5'-UGUGUG-3'. RBM38 is expressed during the middle stage of erythropoiesis. We first confirmed that RBM38 binds specifically with the ISE2 element in vitro The knockdown of RBM38 significantly decreases the level of spliced mRNA at D2 that encodes the 11-kDa protein but not that of the D2-spliced mRNA that encodes VP2. Importantly, we found that the 11-kDa protein enhances viral DNA replication and virion release. Accordingly, the knockdown of RBM38 decreases virus replication via downregulating 11-kDa protein expression. Taken together, these results suggest that the 11-kDa protein facilitates B19V DNA replication and that RBM38 is an essential host factor for B19V pre-mRNA splicing and for the expression of the 11-kDa protein.IMPORTANCE B19V is a human pathogen that can cause fifth disease, arthropathy, anemia in immunocompromised patients and sickle cell disease patients, myocarditis, and hydrops fetalis in pregnant women. Human erythroid progenitor cells (EPCs) are most susceptible to B19V infection and fully support viral DNA replication. The exclusive tropism of B19V for erythroid-lineage cells is dependent not only on the expression of viral receptors and coreceptors on the cell surface but also on the intracellular host factors that support B19V replication. Our present study shows that B19V uses a host factor, RNA binding motif protein 38 (RBM38), for the processing of its pre-mRNA during virus replication. Specifically, RBM38 interacts with the intronic splicing enhancer 2 (ISE2) element of B19V pre-mRNA and promotes 11-kDa protein expression, thereby regulating the 11-kDa protein-mediated augmentation of B19V replication. The identification of this novel host-pathogen interaction will provide mechanistic insights into B19V replication and aid in finding new targets for anti-B19V therapeutics.
Assuntos
Replicação do DNA/fisiologia , DNA Viral/metabolismo , Regulação para Baixo/fisiologia , Eritema Infeccioso/metabolismo , Regulação Viral da Expressão Gênica/fisiologia , Parvovirus B19 Humano/fisiologia , Proteínas de Ligação a RNA/metabolismo , Proteínas não Estruturais Virais/biossíntese , Replicação Viral/fisiologia , DNA Viral/genética , Eritema Infeccioso/genética , Humanos , Proteínas de Ligação a RNA/genética , Proteínas não Estruturais Virais/genéticaRESUMO
The early steps of human parvovirus B19 (B19V) infection were investigated in UT7/Epo cells. B19V and its receptor globoside (Gb4Cer) associate with lipid rafts, predominantly of the noncaveolar type. Pharmacological disruption of the lipid rafts inhibited infection when the drug was added prior to virus attachment but not after virus uptake. B19V is internalized by clathrin-dependent endocytosis and spreads rapidly throughout the endocytic pathway, reaching the lysosomal compartment within minutes, where a substantial proportion is degraded. B19V did not permeabilize the endocytic vesicles, indicating a mechanism of endosomal escape without apparent membrane damage. Bafilomycin A(1) (BafA1) and NH(4)Cl, which raise endosomal pH, blocked the infection by preventing endosomal escape, resulting in a massive accumulation of capsids in the lysosomes. In contrast, in the presence of chloroquine (CQ), the transfer of incoming viruses from late endosomes to lysosomes was prevented; the viral DNA was not degraded; and the infection was boosted. In contrast to the findings for untreated or BafA1-treated cells, the viral DNA was progressively associated with the nucleus in CQ-treated cells, reaching a plateau by 3 h postinternalization, a time coinciding with the initiation of viral transcription. At this time, more than half of the total intracellular viral DNA was associated with the nucleus; however, the capsids remained extranuclear. Our studies provide the first insight into the early steps of B19V infection and reveal mechanisms involved in virus uptake, endocytic trafficking, and nuclear penetration.
Assuntos
Eritema Infeccioso/virologia , Parvovirus B19 Humano/fisiologia , Linhagem Celular , Núcleo Celular/virologia , Endocitose , Endossomos/virologia , Eritema Infeccioso/metabolismo , Globosídeos/metabolismo , Humanos , Lisossomos/virologia , Receptores Virais/metabolismoRESUMO
Human parvovirus B19 (B19V) causes a variety of human diseases. Disease outcomes of bone marrow failure in patients with high turnover of red blood cells and immunocompromised conditions, and fetal hydrops in pregnant women are resulted from the targeting and destruction of specifically erythroid progenitors of the human bone marrow by B19V. Although the ex vivo expanded erythroid progenitor cells recently used for studies of B19V infection are highly permissive, they produce progeny viruses inefficiently. In the current study, we aimed to identify the mechanism that underlies productive B19V infection of erythroid progenitor cells cultured in a physiologically relevant environment. Here, we demonstrate an effective reverse genetic system of B19V, and that B19V infection of ex vivo expanded erythroid progenitor cells at 1% O(2) (hypoxia) produces progeny viruses continuously and efficiently at a level of approximately 10 times higher than that seen in the context of normoxia. With regard to mechanism, we show that hypoxia promotes replication of the B19V genome within the nucleus, and that this is independent of the canonical PHD/HIFα pathway, but dependent on STAT5A and MEK/ERK signaling. We further show that simultaneous upregulation of STAT5A signaling and down-regulation of MEK/ERK signaling boosts the level of B19V infection in erythroid progenitor cells under normoxia to that in cells under hypoxia. We conclude that B19V infection of ex vivo expanded erythroid progenitor cells at hypoxia closely mimics native infection of erythroid progenitors in human bone marrow, maintains erythroid progenitors at a stage conducive to efficient production of progeny viruses, and is regulated by the STAT5A and MEK/ERK pathways.
Assuntos
Eritema Infeccioso/virologia , Células Precursoras Eritroides/virologia , Subunidade alfa do Fator 1 Induzível por Hipóxia/fisiologia , Hipóxia/patologia , MAP Quinase Quinase Quinases/fisiologia , Parvovirus B19 Humano/fisiologia , Fator de Transcrição STAT5/fisiologia , Proteínas Supressoras de Tumor/fisiologia , Antígenos CD36/metabolismo , Diferenciação Celular/fisiologia , Proliferação de Células , Células Cultivadas , Replicação do DNA , Eritema Infeccioso/complicações , Eritema Infeccioso/metabolismo , Células Precursoras Eritroides/metabolismo , Células Precursoras Eritroides/patologia , Células Precursoras Eritroides/fisiologia , Humanos , Hipóxia/complicações , Hipóxia/virologia , Subunidade alfa do Fator 1 Induzível por Hipóxia/metabolismo , MAP Quinase Quinase Quinases/metabolismo , Sistema de Sinalização das MAP Quinases/genética , Sistema de Sinalização das MAP Quinases/fisiologia , Modelos Biológicos , Fator de Transcrição STAT5/metabolismo , Proteínas Supressoras de Tumor/metabolismo , Replicação Viral/genética , Replicação Viral/fisiologiaRESUMO
Giant proerythroblasts are hallmarks of human parvovirus B19 infection. We attempted to characterize these cells in 5 patients with parvovirus B19-induced pure red cell aplasia using immunostaining of paraffin-embedded bone marrow sections with antibodies against erythroid-lineage-specific proteins, viral capsid antigen VP-1, and apoptosis- and cell-cycle-related proteins. Giant proerythroblasts are immunohistochemically consistent with early erythroid precursors of cells in the differentiation stage of CD34-, cytoplasmic spectrin+, glycophorin A-, and band-3-. VP-1 was expressed in the nucleus and cytoplasm of small- to medium-sized spectrin+ erythroid cells but not in giant proerythroblasts. The giant proerythroblasts displayed nuclear staining for p53 (41%+/-16%) and Ki-67 antigen (100%+/-0%) and cytoplasmic staining for Bax (65%+/-11%) and procaspase-3 (78%+/-10%), whereas they were not stained for p21Wafl/Cip1, active form of caspase-3, or terminal deoxynucleotidyltransferase-mediated deoxyuridine nick-end labeling (TUNEL). Antiapoptotic proteins, Bcl-2 and Mcl-1, were not expressed in the giant cells, and Bcl-x was infrequently expressed in these cells (11%+/-4%). These immunohistochemical findings suggest that giant proerythroblasts are proliferating erythroid precursors with accumulation of nonfunctional p53.